Jagsonpal Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has filed a compliance certificate with the Exchange as required under the SEBI (Depositories and Participants) Regulations, 2018. This is a routine filing, typically submitted annually after the company's Annual General Meeting. It confirms the company's compliance with rules around holding and issuing shares in dematerialized (electronic) form through depositories like NSDL and CDSL. No financial numbers, transactions, or strategic decisions are involved in this filing.
This is a standard regulatory compliance submission with no material effect on the company's financials, operations, or stock price. It simply confirms the company is meeting its basic listing and securities-related obligations.